SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Senior who wrote (768)9/18/2000 2:09:52 PM
From: JDN  Read Replies (1) of 783
 
Dear Paul Senior: I think the key to whether or not BCHE will be an outstanding investment is whether or not they will be able to successfully produce and market their next line of drugs themselves. Previously they have had GLAXO marketing and distributing their most successful drug. This has given them considerable cash etc. and decent earnings (especially for the price of the stock) but not a lot of UPSIDE opportunity. At these prices I think its worth dipping your feet in to test the waters. JDN
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News